nodes	percent_of_prediction	percent_of_DWPC	metapath
Icatibant—BDKRB2—respiratory system—allergic rhinitis	0.065	0.192	CbGeAlD
Icatibant—BDKRB2—trachea—allergic rhinitis	0.048	0.142	CbGeAlD
Icatibant—ANPEP—respiratory system—allergic rhinitis	0.0405	0.12	CbGeAlD
Icatibant—BDKRB2—lung—allergic rhinitis	0.0345	0.102	CbGeAlD
Icatibant—ANPEP—epithelium—allergic rhinitis	0.0339	0.0999	CbGeAlD
Icatibant—ANPEP—bronchus—allergic rhinitis	0.0333	0.0984	CbGeAlD
Icatibant—ANPEP—skin of body—allergic rhinitis	0.0322	0.095	CbGeAlD
Icatibant—ANPEP—trachea—allergic rhinitis	0.0299	0.0884	CbGeAlD
Icatibant—ANPEP—lung—allergic rhinitis	0.0215	0.0635	CbGeAlD
Icatibant—BDKRB2—ACE Inhibitor Pathway—TGFB1—allergic rhinitis	0.0195	0.0743	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—PTGDR2—allergic rhinitis	0.0156	0.0596	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (q) signalling events—CYSLTR1—allergic rhinitis	0.0147	0.0561	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	0.0145	0.0553	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CCL11—allergic rhinitis	0.014	0.0535	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—CYSLTR1—allergic rhinitis	0.0132	0.0502	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	0.0124	0.0474	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	0.0114	0.0434	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (q) signalling events—TAC1—allergic rhinitis	0.0103	0.0394	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—TAC1—allergic rhinitis	0.0102	0.0389	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.00974	0.0372	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—PTGDR2—allergic rhinitis	0.00945	0.0361	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.0094	0.0359	CbGpPWpGaD
Icatibant—Anaphylactic shock—Desloratadine—allergic rhinitis	0.0093	0.0233	CcSEcCtD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—allergic rhinitis	0.00923	0.0352	CbGpPWpGaD
Icatibant—Nervous system disorder—Desloratadine—allergic rhinitis	0.00912	0.0228	CcSEcCtD
Icatibant—ANPEP—Cardiac Progenitor Differentiation—TGFB1—allergic rhinitis	0.00857	0.0327	CbGpPWpGaD
Icatibant—ANPEP—C-MYB transcription factor network—CD4—allergic rhinitis	0.00826	0.0315	CbGpPWpGaD
Icatibant—Nervous system disorder—Olopatadine—allergic rhinitis	0.0078	0.0195	CcSEcCtD
Icatibant—BDKRB2—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.00742	0.0283	CbGpPWpGaD
Icatibant—Body temperature increased—Desloratadine—allergic rhinitis	0.00735	0.0184	CcSEcCtD
Icatibant—BDKRB2—GPCR ligand binding—CCL11—allergic rhinitis	0.00716	0.0273	CbGpPWpGaD
Icatibant—Hypersensitivity—Desloratadine—allergic rhinitis	0.00685	0.0172	CcSEcCtD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.00683	0.0261	CbGpPWpGaD
Icatibant—Dizziness—Cyproheptadine—allergic rhinitis	0.00633	0.0158	CcSEcCtD
Icatibant—Body temperature increased—Olopatadine—allergic rhinitis	0.00629	0.0157	CcSEcCtD
Icatibant—Dizziness—Desloratadine—allergic rhinitis	0.00615	0.0154	CcSEcCtD
Icatibant—Rash—Cyproheptadine—allergic rhinitis	0.00603	0.0151	CcSEcCtD
Icatibant—Dermatitis—Cyproheptadine—allergic rhinitis	0.00603	0.0151	CcSEcCtD
Icatibant—Headache—Cyproheptadine—allergic rhinitis	0.00599	0.015	CcSEcCtD
Icatibant—Anaphylactic shock—Loratadine—allergic rhinitis	0.00599	0.015	CcSEcCtD
Icatibant—Nervous system disorder—Loratadine—allergic rhinitis	0.00588	0.0147	CcSEcCtD
Icatibant—Rash—Desloratadine—allergic rhinitis	0.00586	0.0147	CcSEcCtD
Icatibant—Dermatitis—Desloratadine—allergic rhinitis	0.00586	0.0147	CcSEcCtD
Icatibant—Hypersensitivity—Olopatadine—allergic rhinitis	0.00586	0.0147	CcSEcCtD
Icatibant—Headache—Desloratadine—allergic rhinitis	0.00583	0.0146	CcSEcCtD
Icatibant—Nausea—Cyproheptadine—allergic rhinitis	0.00568	0.0142	CcSEcCtD
Icatibant—Anaphylactic shock—Cetirizine—allergic rhinitis	0.00564	0.0141	CcSEcCtD
Icatibant—Nervous system disorder—Cetirizine—allergic rhinitis	0.00553	0.0139	CcSEcCtD
Icatibant—Nausea—Desloratadine—allergic rhinitis	0.00552	0.0138	CcSEcCtD
Icatibant—BDKRB2—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.00534	0.0204	CbGpPWpGaD
Icatibant—Dizziness—Olopatadine—allergic rhinitis	0.00526	0.0132	CcSEcCtD
Icatibant—BDKRB2—GPCR ligand binding—TAC1—allergic rhinitis	0.0052	0.0199	CbGpPWpGaD
Icatibant—Dizziness—Diphenhydramine—allergic rhinitis	0.00515	0.0129	CcSEcCtD
Icatibant—Dizziness—Dimenhydrinate—allergic rhinitis	0.00515	0.0129	CcSEcCtD
Icatibant—Rash—Olopatadine—allergic rhinitis	0.00501	0.0126	CcSEcCtD
Icatibant—Dermatitis—Olopatadine—allergic rhinitis	0.00501	0.0125	CcSEcCtD
Icatibant—Headache—Olopatadine—allergic rhinitis	0.00498	0.0125	CcSEcCtD
Icatibant—Rash—Dimenhydrinate—allergic rhinitis	0.00491	0.0123	CcSEcCtD
Icatibant—Rash—Diphenhydramine—allergic rhinitis	0.00491	0.0123	CcSEcCtD
Icatibant—Dermatitis—Dimenhydrinate—allergic rhinitis	0.0049	0.0123	CcSEcCtD
Icatibant—Dermatitis—Diphenhydramine—allergic rhinitis	0.0049	0.0123	CcSEcCtD
Icatibant—Headache—Dimenhydrinate—allergic rhinitis	0.00488	0.0122	CcSEcCtD
Icatibant—Headache—Diphenhydramine—allergic rhinitis	0.00488	0.0122	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—PTGDR2—allergic rhinitis	0.00485	0.0185	CbGpPWpGaD
Icatibant—Body temperature increased—Loratadine—allergic rhinitis	0.00474	0.0119	CcSEcCtD
Icatibant—Anaphylactic shock—Montelukast—allergic rhinitis	0.00473	0.0118	CcSEcCtD
Icatibant—Nausea—Olopatadine—allergic rhinitis	0.00472	0.0118	CcSEcCtD
Icatibant—Nervous system disorder—Montelukast—allergic rhinitis	0.00464	0.0116	CcSEcCtD
Icatibant—Nausea—Dimenhydrinate—allergic rhinitis	0.00462	0.0116	CcSEcCtD
Icatibant—Nausea—Diphenhydramine—allergic rhinitis	0.00462	0.0116	CcSEcCtD
Icatibant—Body temperature increased—Cetirizine—allergic rhinitis	0.00446	0.0112	CcSEcCtD
Icatibant—Body temperature increased—Flunisolide—allergic rhinitis	0.00438	0.011	CcSEcCtD
Icatibant—BDKRB2—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.00419	0.016	CbGpPWpGaD
Icatibant—Hypersensitivity—Cetirizine—allergic rhinitis	0.00415	0.0104	CcSEcCtD
Icatibant—Hypersensitivity—Flunisolide—allergic rhinitis	0.00409	0.0102	CcSEcCtD
Icatibant—Dizziness—Loratadine—allergic rhinitis	0.00396	0.00993	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.00381	0.0145	CbGpPWpGaD
Icatibant—Rash—Loratadine—allergic rhinitis	0.00378	0.00947	CcSEcCtD
Icatibant—Dermatitis—Loratadine—allergic rhinitis	0.00378	0.00946	CcSEcCtD
Icatibant—Headache—Loratadine—allergic rhinitis	0.00375	0.0094	CcSEcCtD
Icatibant—Body temperature increased—Montelukast—allergic rhinitis	0.00374	0.00936	CcSEcCtD
Icatibant—Dizziness—Cetirizine—allergic rhinitis	0.00373	0.00934	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—CCL11—allergic rhinitis	0.00368	0.014	CbGpPWpGaD
Icatibant—Dizziness—Flunisolide—allergic rhinitis	0.00367	0.00918	CcSEcCtD
Icatibant—Nausea—Loratadine—allergic rhinitis	0.00356	0.00892	CcSEcCtD
Icatibant—Rash—Cetirizine—allergic rhinitis	0.00356	0.00891	CcSEcCtD
Icatibant—Dermatitis—Cetirizine—allergic rhinitis	0.00355	0.0089	CcSEcCtD
Icatibant—Headache—Cetirizine—allergic rhinitis	0.00353	0.00885	CcSEcCtD
Icatibant—Rash—Flunisolide—allergic rhinitis	0.0035	0.00876	CcSEcCtD
Icatibant—Dermatitis—Flunisolide—allergic rhinitis	0.00349	0.00875	CcSEcCtD
Icatibant—Hypersensitivity—Montelukast—allergic rhinitis	0.00348	0.00873	CcSEcCtD
Icatibant—Headache—Flunisolide—allergic rhinitis	0.00347	0.0087	CcSEcCtD
Icatibant—Nausea—Cetirizine—allergic rhinitis	0.00335	0.00839	CcSEcCtD
Icatibant—Nausea—Flunisolide—allergic rhinitis	0.00329	0.00825	CcSEcCtD
Icatibant—Dizziness—Montelukast—allergic rhinitis	0.00313	0.00783	CcSEcCtD
Icatibant—Rash—Montelukast—allergic rhinitis	0.00298	0.00747	CcSEcCtD
Icatibant—Dermatitis—Montelukast—allergic rhinitis	0.00298	0.00746	CcSEcCtD
Icatibant—Headache—Montelukast—allergic rhinitis	0.00296	0.00742	CcSEcCtD
Icatibant—BDKRB2—GPCR downstream signaling—TAC1—allergic rhinitis	0.00294	0.0112	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PTGDR2—allergic rhinitis	0.00286	0.0109	CbGpPWpGaD
Icatibant—Nausea—Montelukast—allergic rhinitis	0.00281	0.00704	CcSEcCtD
Icatibant—BDKRB2—GPCR downstream signaling—IL5—allergic rhinitis	0.00273	0.0104	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—TAC1—allergic rhinitis	0.00267	0.0102	CbGpPWpGaD
Icatibant—Anaphylactic shock—Prednisolone—allergic rhinitis	0.00261	0.00655	CcSEcCtD
Icatibant—Anaphylactic shock—Hydrocortisone—allergic rhinitis	0.00255	0.0064	CcSEcCtD
Icatibant—Nervous system disorder—Hydrocortisone—allergic rhinitis	0.0025	0.00627	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—IL5—allergic rhinitis	0.00248	0.00948	CbGpPWpGaD
Icatibant—Anaphylactic shock—Triamcinolone—allergic rhinitis	0.0024	0.00602	CcSEcCtD
Icatibant—Anaphylactic shock—Methylprednisolone—allergic rhinitis	0.0024	0.00601	CcSEcCtD
Icatibant—Nervous system disorder—Methylprednisolone—allergic rhinitis	0.00235	0.00589	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—CYSLTR1—allergic rhinitis	0.00225	0.00858	CbGpPWpGaD
Icatibant—Anaphylactic shock—Dexamethasone—allergic rhinitis	0.00218	0.00546	CcSEcCtD
Icatibant—Anaphylactic shock—Betamethasone—allergic rhinitis	0.00218	0.00546	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—CCL11—allergic rhinitis	0.00217	0.00829	CbGpPWpGaD
Icatibant—Nervous system disorder—Dexamethasone—allergic rhinitis	0.00214	0.00536	CcSEcCtD
Icatibant—Nervous system disorder—Betamethasone—allergic rhinitis	0.00214	0.00536	CcSEcCtD
Icatibant—Body temperature increased—Hydrocortisone—allergic rhinitis	0.00202	0.00506	CcSEcCtD
Icatibant—Hypersensitivity—Prednisolone—allergic rhinitis	0.00193	0.00483	CcSEcCtD
Icatibant—Body temperature increased—Triamcinolone—allergic rhinitis	0.0019	0.00476	CcSEcCtD
Icatibant—Hypersensitivity—Hydrocortisone—allergic rhinitis	0.00188	0.00471	CcSEcCtD
Icatibant—Hypersensitivity—Triamcinolone—allergic rhinitis	0.00177	0.00444	CcSEcCtD
Icatibant—Hypersensitivity—Methylprednisolone—allergic rhinitis	0.00177	0.00443	CcSEcCtD
Icatibant—Dizziness—Prednisolone—allergic rhinitis	0.00173	0.00433	CcSEcCtD
Icatibant—Body temperature increased—Betamethasone—allergic rhinitis	0.00172	0.00432	CcSEcCtD
Icatibant—Body temperature increased—Dexamethasone—allergic rhinitis	0.00172	0.00432	CcSEcCtD
Icatibant—Dizziness—Hydrocortisone—allergic rhinitis	0.00169	0.00423	CcSEcCtD
Icatibant—Rash—Prednisolone—allergic rhinitis	0.00165	0.00413	CcSEcCtD
Icatibant—Dermatitis—Prednisolone—allergic rhinitis	0.00165	0.00413	CcSEcCtD
Icatibant—Headache—Prednisolone—allergic rhinitis	0.00164	0.0041	CcSEcCtD
Icatibant—Rash—Hydrocortisone—allergic rhinitis	0.00161	0.00403	CcSEcCtD
Icatibant—Dermatitis—Hydrocortisone—allergic rhinitis	0.00161	0.00403	CcSEcCtD
Icatibant—Headache—Hydrocortisone—allergic rhinitis	0.0016	0.00401	CcSEcCtD
Icatibant—Dizziness—Triamcinolone—allergic rhinitis	0.00159	0.00398	CcSEcCtD
Icatibant—Dizziness—Methylprednisolone—allergic rhinitis	0.00159	0.00397	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—TAC1—allergic rhinitis	0.00158	0.00602	CbGpPWpGaD
Icatibant—Nausea—Prednisolone—allergic rhinitis	0.00155	0.00389	CcSEcCtD
Icatibant—Nausea—Hydrocortisone—allergic rhinitis	0.00152	0.0038	CcSEcCtD
Icatibant—Rash—Triamcinolone—allergic rhinitis	0.00152	0.0038	CcSEcCtD
Icatibant—Dermatitis—Triamcinolone—allergic rhinitis	0.00151	0.00379	CcSEcCtD
Icatibant—Rash—Methylprednisolone—allergic rhinitis	0.00151	0.00379	CcSEcCtD
Icatibant—Dermatitis—Methylprednisolone—allergic rhinitis	0.00151	0.00379	CcSEcCtD
Icatibant—Headache—Triamcinolone—allergic rhinitis	0.00151	0.00377	CcSEcCtD
Icatibant—Headache—Methylprednisolone—allergic rhinitis	0.0015	0.00376	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—IL5—allergic rhinitis	0.00147	0.0056	CbGpPWpGaD
Icatibant—Dizziness—Betamethasone—allergic rhinitis	0.00144	0.00361	CcSEcCtD
Icatibant—Dizziness—Dexamethasone—allergic rhinitis	0.00144	0.00361	CcSEcCtD
Icatibant—Nausea—Triamcinolone—allergic rhinitis	0.00143	0.00358	CcSEcCtD
Icatibant—Nausea—Methylprednisolone—allergic rhinitis	0.00143	0.00357	CcSEcCtD
Icatibant—Rash—Betamethasone—allergic rhinitis	0.00138	0.00345	CcSEcCtD
Icatibant—Rash—Dexamethasone—allergic rhinitis	0.00138	0.00345	CcSEcCtD
Icatibant—Dermatitis—Betamethasone—allergic rhinitis	0.00137	0.00344	CcSEcCtD
Icatibant—Dermatitis—Dexamethasone—allergic rhinitis	0.00137	0.00344	CcSEcCtD
Icatibant—Headache—Dexamethasone—allergic rhinitis	0.00137	0.00342	CcSEcCtD
Icatibant—Headache—Betamethasone—allergic rhinitis	0.00137	0.00342	CcSEcCtD
Icatibant—Nausea—Betamethasone—allergic rhinitis	0.0013	0.00325	CcSEcCtD
Icatibant—Nausea—Dexamethasone—allergic rhinitis	0.0013	0.00325	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—SMAD3—allergic rhinitis	0.00103	0.00394	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—NFKB1—allergic rhinitis	0.000525	0.002	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—TGFB1—allergic rhinitis	0.000437	0.00167	CbGpPWpGaD
